You are here

patent cliffs

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma

Fri, 09/8/23 - 10:29 am

BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's

Fierce Pharma

Tue, 06/21/22 - 11:56 pm

Bristol Myers Squibb

JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff

Fierce Pharma

Mon, 01/10/22 - 11:49 pm

Bristol Myers Squibb

Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers

Fierce Pharma

Fri, 12/31/21 - 11:10 am

Bristol Myers Squibb

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

TheStreet.com

Tue, 06/13/17 - 05:48 pm

Pharma Starts a Feedback Loop

Drug Patent Watch

Mon, 06/12/17 - 10:08 am

patent expirations

drug development